7151-04-4

5,5-bis(ethylsulfanyl)-2,3,4-trihydroxypentyl benzoate

Catalog No.	818553
Name	5,5-bis(ethylsulfanyl)-2,3,4-trihydroxypentyl benzoate
CAS	7151-04-4
Formula	C16H24 O5 S2
Boiling Point	298.4 ( ℃ )

Request a Quote

Benzoic acid, 4-([1,1'-biphenyl]-2-ylmethoxy)-3-chloro-

Methanone, 2-naphthalenyl(3-phenylnaphtho[1,2-b]furan-2-yl)-

Dimethylaniline oxidase

1,3-PHENYLENE DIACRYLATE

N,N',N''-triethyl-N,N',N''-tris(hydroxymethyl)phosphoric triamide

(2-cyanoethyl)ammonium hydrogen fumarate

Benzoic acid, 4-[(2-benzoylphenoxy)methyl]-

3-Pentyn-2-ol, 5-(phenylthio)-

E.C. 1.14.13.4

2-(2-Pyridyl)-quinolin-4-amine

1-ethyl-2-methyl-cyclopentane

nonylbenzenesulphonic acid

dodec-11-enol

1H-Imidazo[4,5-h]quinolin-5-amine,1-methyl-

Oxygenase,androstenedione mono-

37256-74-9

E.C.1.5.1.9

Oxygenase,5-pyridoxate di-

E.C.1.8.4.3

E.C. 3.4.99.15

L-Aspartic acid, N-[(2E)-3-(2-furanyl)-1-oxo-2-propenyl]-, dimethyl ester

E.C. 2.1.1.27

L-Valine, N-[(2E)-3-(2-furanyl)-1-oxo-2-propenyl]-, methyl ester

CmN3O9

1,3-Benzodioxole-5-carboxaldehyde, 6-[2-(dimethylamino)ethyl]-

Acetic acid, [4-([1,1'-biphenyl]-2-ylmethoxy)phenoxy]-

METHYL-CIS-6-PENTADECENYL PIPERIDINE, CIS

Benzoic acid, 4-[[(2-acetyl-1-naphthalenyl)oxy]methyl]-

4H-1,3-Benzodioxin, 8-(chloromethyl)-5-fluoro-

Blood-group substance B-dependentgalactosyltransferase

Benzoic acid, 4-(2,2-dimethyl-1-oxopropoxy)-3-methoxy-

122665-61-6

Benzo[b]thiophene, compd. with 2,4,6-trinitrophenol (1:1)

PINOSYLVIN MONO METHYL ETHER

1-Isotenuipine

4-Decen-3-one, 2-methyl-, (4E)-

N-ethyl-5-(3,4,5-trimethoxyphenyl)-1,3,4-thiadiazol-2-amine

2-[(1R,2E)-3,4,4aβ,4b,5,6,7,8,8aβ,9,10,10aα-Dodecahydro-7α-hydroxy-1β,4bα,8,8-tetramethyl-10-oxophenanthren-2(1H)-ylidene]-N-(2-hydroxyethyl)-N-methylacetamide

7151-04-4 msds

CAS No 7151-04-4 supplier

CASNo 7151-04-4 distributor

CAS # 7151-04-4 manufacturer

CAS Number 7151-04-4 safety

CAS RN 7151-04-4 wholesale

2025-12-22 Find 5,5-bis(ethylsulfanyl)-2,3,4-trihydroxypentyl benzoate ,CAS No.7151-04-4,Formula:C16H24 O5 S2 in KingPharm Group